Real-time enrollment status for this atypical hemolytic uremic syndrome clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT03205995 |
| Recruiting Status | Terminated |
| Condition | Atypical Hemolytic Uremic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Omeros Corporation |
| Last Updated on CT.gov | December 10, 2025 (Dec 10, 2025) |
As of March 2, 2026: Clinical trial NCT03205995 is currently terminated participants. This clinical trial study for atypical hemolytic uremic syndrome is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Omeros Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03205995 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03205995 was last updated Dec 10, 2025 (December 10, 2025). HelloStudys verifies this status automatically.